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ABSTRACT
Background and objective: There are limited data
regarding patients with PAPVD with suspected and
diagnosed PH.
Methods: Patients with PAPVD presenting to a large PH
referral centre during 2007–2017 were identified from
the ASPIRE registry.
Results: Ninety patients with PAPVD were identified;
this was newly diagnosed at our unit in 71 patients
(78%), despite 69% of these having previously undergone
CT. Sixty-seven percent had a single right superior and
23% a single left superior anomalous vein. Patients with
an SV-ASD had a significantly larger RV area, pulmonary
artery and L-R shunt and a higher % predicted DLCO (all
P < 0.05). Sixty-five patients were diagnosed with PH
(defined as mPAP ≥ 25 mm Hg), which was post-capillary
in 24 (37%). No additional causes of PH were identified
in 28 patients; 17 of these (26% of those patients with
PH) had a PVR > 3 WU. Seven of these patients had iso-
lated PAPVD, five of whom (8% of those patients with
PH) had anomalous drainage of a single pulmonary vein.
Conclusion: Undiagnosed PAPVD with or without ASD
may be present in patients with suspected PH; cross-
sectional imaging should therefore be specifically
assessed whenever this diagnosis is considered. Radio-
logical and physiological markers of L-R shunt are
higher in patients with an associated SV-ASD. Although
many patients with PAPVD and PH may have other
potential causes of PH, a proportion of patients diag-
nosed with PAH have isolated PAPVD in the absence of
other causative conditions.
Key words: anomalous pulmonary venous drainage, atrial
septal defect, pulmonary hypertension, sinus venosus.
INTRODUCTION
Anomalous pulmonary venous drainage (APVD)
describes a pattern where one of more of the pulmo-
nary veins do not drain into the left atrium but instead are
connected to the right atrium, superior or inferior vena
cava, azygous vein, coronary sinus or brachiocephalic vein.
The prevalence of APVD in adults was found to be 0.1% in
a large study involving 45 538 consecutive thoracic com-
puted tomography (CT) scans.1
Total APVD presents early in life with neonatal distress
and circulatory compromise. Partial APVD (PAPVD) may
present later in life due to symptoms related to a volume-
loaded right ventricle (as a result of left-to-right (L-R)
shunting) or subsequent development of pulmonary arte-
rial (PA) hypertension (PAH).2,3 Alternatively, patients
may remain asymptomatic and PAPVD be diagnosed inci-
dentally. PAPVD is commonly associated with other con-
genital heart defects, particularly sinus venosus atrial
septal defects (SV-ASD).4–7 Once diagnosed, management
of patients with PAPVD may involve surgical correction,
may be conservative ormay involvemedical therapy.2
Due to right ventricular (RV) dilatation resulting from
L-R shunting and/or the development of pulmonary
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SUMMARY AT A GLANCE
PAPVD was frequently missed in patients presenting
with suspected PH. L-R shunt was higher in patients
with associated ASD. Although patients may have
other potential causes of PH, some patients with
PAH have isolated PAPVD without other causative
conditions.
© 2020 The Authors.
Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.
Respirology (2020)
doi: 10.1111/resp.13815
hypertension (PH), patients with PAPVD may present to
PH referral centres but there are few published data
regarding patients with suspected or proven PH and
coexisting APVD. We therefore performed a study to
assess patients with PAPVD presenting to a large PH
referral centre over a 10-year period.
METHODS
Records for all patients seen at a large PH referral cen-
tre between 2007 and 2017 were assessed for evidence
of APVD. Approval by the relevant ethics committee
was sought and gained (STH14169, NHS Research
Ethics Committee 16/YH/0352), and written consent
was waived.
Hospital databases, including the ASPIRE (Assessing
the Spectrum of Pulmonary hypertension Identified at
a REferral centre) registry and electronic medical
records, were interrogated for keywords including
‘anomalous’, ‘pulmonary venous drainage’, ‘pulmonary
venous return’, ‘scimitar’ and ‘sinus venosus’. Patients
who had undergone corrective surgery for PAPVD prior
to being seen were excluded, as were those whose cases
had been referred or discussed, but not formally seen at
our centre. Data regarding associated structural abnor-
malities, comorbidities, pulmonary haemodynamics and
mortality status at the census date of 31 May 2017 were
collected. Pulmonary venous anatomy had been assessed
on CT imaging (contrast-enhanced in 88 patients). Car-
diac chamber area, PA and aortic diameter were subse-
quently measured by one author (R.A.L.), blinded to
clinical details. Cardiac magnetic resonance (CMR) imag-
ing had been performed in a proportion of patients; pul-
monary to systemic shunt assessments (Qp:Qs) derived
from phase-contrast flow measurements were retrieved.
Spirometry was available for 97% and percent-predicted
diffusing capacity for carbon monoxide (DLCO %pred) for
89% of patients. At cardiac catheterization, cardiac output
was measured by thermodilution. PH was defined as
mean PA pressure (mPAP) ≥ 25 mm Hg, in keeping with
the definition at the time of study enrolment.
Patients with uncorrected PAPVD who had under-
gone corrective surgery for an ASD were included in
the study but were excluded from comparison against
patients with isolated PAPVD. Regional adult congeni-
tal heart disease (ACHD) centres were contacted to
establish whether patients seen at our centre had sub-
sequently received any surgical intervention for PAPVD
or ASD.
Statistical analysis was performed using SPSS v25 (IBM,
New York, NY, USA) and GraphPad Prism v8 (San Diego,
CA, USA). Continuous data were presented with
mean  SD. Comparison between groups was performed
using the unpaired t-test and response to treatment using
the paired t-test. A P-value of <0.05 was considered
significant.
RESULTS
Demographics
Ninety patients with PAPVD were identified from
our departmental databases. Demographics and
haemodynamic and radiological data are displayed in
Table 1. Hemodynamic data are displayed visually in
Figure 1. The majority of patients were female (70%)
with a mean age of 60 years. During the course of the
study, 4240 patients were assessed and assigned a
specific PH diagnosis at our unit, resulting in an esti-
mated prevalence of 2.1% in this population.
Pulmonary venous anatomy
Seventy-one patients (79%) were newly diagnosed with
PAPVD following review at the unit; 49 of these
71 patients (69%) had previously undergone contrast-
enhanced CT locally where the anomalous venous
drainage had not been appreciated. An SV-ASD was
visible on cross-sectional imaging in 31 patients (34%);
the SV-ASD had not been previously diagnosed in
25 (81%) of these patients (Fig. 2). PAPVD was isolated
(i.e. there was no evidence of an associated ASD) in
47 patients. Six further patients had previously under-
gone ASD repair but still had PAPVD.
The majority of patients had abnormal drainage lim-
ited to the right superior vein (n = 60, 67%; Table 1). Of
these, 44 had isolated right upper lobe abnormal drain-
age while 16 had combined right upper and middle
lobe abnormalities. Twenty-one patients (23%) had an
Table 1 Baseline demographics
Age (years) 60.4  15.2
Gender (% female) 70
WHO functional class I/II/III/IV (%) 0/24/68/8
Lung function
FEV1 (%pred) 70.4  20.5
FVC (%pred) 85.0  22.4
FEV1/FVC (%) 68.3  11.4
DLCO (%pred) 73.5  23.6
ISWD (m) 227  166
Haemodynamics
mRAP (mm Hg) 11  7
mPAP (mm Hg) 39  15
PAWP (mm Hg) 14.0  7.0
CO (L/min) 5.9  1.9
CI (L/min/m2) 3.2  0.9
PVR (WU) 4.8  3.8
PVRi (WU.m2) 8.4  6.3
PA saturations (%) 78  8
Anatomical defect (%)
Right superior vein 66.7
Total right 4.4
Left superior vein 23.4
Right and left superior vein 4.4
Total left 1.1
Haemodynamics measured at right heart catheterization
include mRAP, mPAP, PAWP, CO, CI, PVR, PVRi and PA.
CI, cardiac index; CO, cardiac output; DLCO, diffusing capacity
for carbon monoxide; FEV1, forced expiratory volume in 1 s;
FVC, forced vital capacity; ISWD, incremental shuttle walking
test distance; mPAP, mean PA pressure; mRAP, mean right atrial
pressure; PA, pulmonary arterial; PAWP, PA wedge pressure;
PVR, pulmonary vascular resistance; PVRi, PVR indexed for body
surface area; WHO, World Health Organization; WU, Wood unit.
© 2020 The Authors.
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isolated left superior vein anomaly. Five patients (6%)
had anomalous connection of an entire lung; the right
lung was affected in four patients and the left lung in
one patient.
Pulmonary haemodynamics
Eighty patients (89%) underwent right heart catheteri-
zation (RHC) and 64 (79% of those undergoing RHC)
were found to have PH as defined at the time of study
enrolment by a mPAP ≥ 25 mm Hg. A further patient
with Eisenmenger physiology did not undergo RHC.
PH was post-capillary (as defined by a PA wedge pres-
sure (PAWP) > 15 mm Hg) in 24 (37%) patients.
Measurement of pressure in the wedged position of
the pulmonary artery supplying lung with anomalous
venous drainage will actually measure right atrial pres-
sure. As the lobe in which the PAWP was measured was
not recorded at the time of catheterization, we therefore
compared the left atrial (LA) area, measured on CT, of
those with a PAWP of ≤15 and >15 mm Hg. LA area was
significantly larger (31.4 vs 20.1 cm2, P < 0.0005) in
patients with a PAWP > 15 mm Hg.
Cardiac anatomy
Cardiac chamber measurements for patients who had
isolated PAPVD compared with those with an associ-
ated ASD are displayed in Table 2. Patients with
isolated PAPVD had a smaller RV area (31.6 vs
38.6 cm2, P = 0.001). There was no significant differ-
ence for LA area (22.8 vs 22.9 cm2) or right atrial area
(30.8 vs 33.0 cm2, respectively) between the two groups.
Patients with an associated ASD did, however, have a
larger pulmonary artery diameter (3.9 vs 3.4 cm,
P = 0.003). Right atrial, RV and LA areas were larger in
patients with an elevated PAWP (all P < 0.01) while
there was a trend towards a larger pulmonary artery in
those with an elevated PAWP (P = 0.053).
Shunt data
Qp:Qs as assessed by flow measurements at cardiac MRI
(CMR, performed in 43 patients) was significantly higher
in patients with an associated SV-ASD compared to those
without (2.2:1 vs 1.5:1, P = 0.006). Percent-predicted DLCO
was significantly higher in patients with an associated SV-
ASD (81% vs 67%, P < 0.05). There was no significant dif-
ference in CMR-derived Qp:Qs between those patients
with a normal versus an elevated PAWP.
Single versus multiple APVD
In those with isolated PAPVD, both Qp:Qs measured at
CMR and DLCO %pred were higher (1.8:1 vs 1.3:1 and
83% vs 63%, respectively, both P < 0.05) in those with
anomalous pulmonary veins draining >1 lobe. An
mPAP ≥ 25 mm Hg was observed in 27 patients with
mPAP (mm Hg)
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Figure 1 Scatter plot demonstrating haemodynamic parameters for all patients with PAPVD, categorized by PAWP ≤15 mm Hg ( )
and >15 mm Hg ( ). mPAP, mean PA pressure; PA, pulmonary arterial; PAPVD, partial anomalous pulmonary venous drainage; PAWP,
PA wedge pressure; PVR, pulmonary vascular resistance.
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isolated anomalous drainage of a single pulmonary
vein. Of these patients, 17 (63%) had a pulmonary vas-
cular resistance (PVR) > 3 Wood unit (WU).
Comorbidities
Additional possible causes of PH were present in 37 of
65 patients with PH (57%): elevated LA pressure
(n = 18), significant lung disease (n = 8), combined ele-
vated LA pressure and lung disease (n = 4), chronic
thromboembolic disease (n = 4), cirrhosis (n = 2) and
hereditary haemorrhagic telangiectasia (n = 1). One
patient with chronic thromboembolic disease and one
patient with cirrhosis also had an elevated PAWP. No
additional causes of PH were identified in 28 patients
(43%). Of these 28 patients, 17 (26% of those patients
with PH) had a PVR > 3 WU. Seven (11% of those with
PH) of these patients had isolated PAPVD, five of
whom (8% of those patients with PH) had anomalous
drainage of a single pulmonary vein.
Follow-up and outcomes
By the census date, 16 patients (18%) had died. Fifteen
patients were already known to congenital heart disease
units prior to being seen at our centre. Fifty-three patients
were subsequently referred by us to regional ACHD centres
for assessment for re-routing of anomalous pulmonary
veins and/or closure of ASD. Fifteen patients were identi-
fied as being appropriate for surgical intervention (mPAP:
28  8 mm Hg, mean PAWP: 11  4 mm Hg, PVR:
2.6 0.9WU) and 13 chose to have surgical correction per-
formed. Of these 15 patients, 11 had an associated SV-ASD
with 3 of the 4 patients without an SV-ASD having abnor-
mal drainage of >1 pulmonary vein. Twenty-nine PH
patients (mPAP: 50  9 mm Hg, mean PAWP: 10  4 mm
Hg, PVR: 8.4  3.5 WU) received a trial of PAH therapy
Figure 2 Flow chart demonstrating frequency of SV-ASD and haemodynamic parameters in patients with PAPVD. mPAP, mean PA
pressure; PA, pulmonary arterial; PAPVD, partial anomalous pulmonary venous drainage; PAWP, PA wedge pressure; PVR, pulmonary
vascular resistance; RHC, right heart catheterization; SV-ASD, sinus venosus atrial septal defect.
© 2020 The Authors.
Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.
Respirology (2020)
4 RA Lewis et al.
(phosphodiesterase-5 inhibitor,n = 19; endothelin receptor
antagonist, n = 4; oral combination therapy, n = 2 and
prostanoid-based therapy, n = 4). Mean improvement in
incremental shuttle walking distance from baseline to first
follow-up in the 25 patients with follow-up data following
initiation of PAH therapy was 23 m (P = 0.2).
DISCUSSION
In the current study, we describe our experience of
patients with PAPVD referred to a PH referral centre
over a 10-year period. To our knowledge, this repre-
sents the largest, to date, published cohort of patients
with PAPVD-associated PH.
Of the 90 patients with PAPVD, 71 (79%) had not
been previously identified as having congenital heart
disease, despite CT scanning having been performed
locally prior to referral in 49 (54%) patients. Further-
more, of the 31 patients with an ASD visible on CT, the
diagnosis was newly made by our unit in 25. Jujo et al.
previously studied eight patients identified with PAPVD
at RHC over a 12-year period and found that the diag-
nosis had been missed on initial reporting of CT scans
in 50% of cases.8 Our new data highlight the impor-
tance of considering the possibility of APVD with or
without ASD in all patients in whom PH is suspected. It
can be difficult to identify APVD and SV-ASD using
standard transthoracic echocardiography.9 Many
patients undergo CT scanning prior to referral to a PH
specialist centre and, as part of a systematic evaluation
of the thoracic CT, the course of all four pulmonary
veins should be assessed (Fig. 3).
The majority of patients (67%) had anomalous drain-
age limited to the right superior pulmonary vein, with
29% involving left-sided veins. Most previous clinical
series of patients presenting with symptomatic PAPVD
also reported predominantly right-sided PAPVD,
although two recent population-based CT studies
observed a left-sided predominance.1,10 The reason for
this discrepancy is not clear. In keeping with previous
studies, however, we identified that the majority of
patients with PAPVD in our cohort were female.1,10,11
We hypothesized that patients with >1 anomalous
vein in the absence of an ASD would have evidence of
greater L-R shunt than those with a single abnormal
vein. Although there was no difference in terms of RV
area on CT, we did observe a greater Qp:Qs and higher
DLCO %pred in patients with abnormal drainage of
multiple lobes. This is consistent with previous obser-
vations by Majdalany et al. who reported 43 patients
with isolated PAPVD seen during a 20-year period; the
vast majority of patients with RV dilatation who
required surgery had >1 abnormal pulmonary vein.12
We similarly hypothesized that the 31 patients with
associated ASD would have larger L-R shunts than
those without associated defects and, indeed, in those
patients RV and pulmonary artery diameters and CMR-
assessed Qp:Qs were higher. We also hypothesized that
this increased Qp:Qs would be reflected in standard
non-invasive physiological measurements. DLCO %pred
was higher in those patients with associated septal
defects, in keeping with increased pulmonary capillary
blood flow. These observations were contrary to those
of Sahay et al. who did not see any effect of the pres-
ence or absence of an associated ASD difference on
Table 2 Comparison of patients with isolated PAPVD and PAPVD + ASD†
Isolated PAPVD (n = 47) PAPVD and ASD (n = 37) P-value
CT measurements
Aorta (cm) 3.1  0.5 3.0  0.5 0.286
PA (cm) 3.4  0.6 3.9  0.7 0.003
LA (cm2) 22.8  9.3 22.9  7.0 0.956
RA (cm2) 30.8  14.3 33.0  12.6 0.495
RV (cm2) 31.6  8.5 38.6  8.5 0.001
Qp:Qs (cardiac MRI)‡ 1.5  0.4: 1 2.2  0.9: 1 0.006
DLCO (%pred) 67.4  24.1 80.6  20.7 0.015
Haemodynamics
mRAP (mm Hg) 10.9  6.4 10.1  6.3 0.609
mPAP (mm Hg) 36.7  15.5 41.4  15.7 0.209
PAWP (mm Hg) 13.2  6.5 13.1  7.1 0.955
CO (L/min) 5.9  2.0 5.9  1.7 0.962
CI (L/min/m2) 3.2  1.0 3.3  0.8 0.559
PVR (WU) 4.8  3.9 4.7  3.2 0.868
PVRi (WU.m2) 8.9  7.4 8.5  5.0 0.791
PA saturations (%) 76  8 80  7 0.064
Haemodynamics measured at right heart catheterization include mRAP, mPAP, PAWP, CO, CI, PVR, PVRi and PA.
†Patients with a previously closed ASD were not included in this analysis.
‡Forty-three patients had data available from cardiac MRI.
ASD, atrial septal defect; CI, cardiac index; CO, cardiac output; CT, computed tomography; DLCO, diffusing capacity for carbon mon-
oxide; LA, left atrial; mPAP, mean PA pressure; mRAP, mean right atrial pressure; PA, pulmonary arterial; PAPVD, partial anomalous
pulmonary venous drainage; PAWP, PA wedge pressure; PVR, pulmonary vascular resistance; PVRi, PVR indexed for body surface
area; Qp:Qs, pulmonary to systemic shunt assessment; RA, right atrium; RV, right ventricular; WU, Wood unit.
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Qp:Qs in patients identified at a large ACHD centre
over a 5-year period.13 The number of patients in that
study was, however, relatively small (n = 14, 6 of whom
had PAH).
LA pressure as assessed by PAWP was elevated in
24 patients. In a normal person, each pulmonary vein
drains approximately 25% of the total pulmonary blood
flow.14 However, in anomalous pulmonary vein drainage,
the shunt flow may be higher as the circulation is prefer-
entially directed to the right side due to lower pressure in
the RA and superior vena cava than in the left atrium.
This effect becomes more pronounced in conditions that
increase LA pressure such as systemic hypertension or
left heart disease. It is interesting to note that the right-
sided chambers were significantly larger and there was a
trend towards a larger pulmonary artery in those patients
with an elevated PAWP.
In addition to elevated LA pressure, other potential
causes of PH were present in 29% of patients with PH. In
their report of 43 patients with isolated PAPVD,
Majdalany et al. observed emphysema or interstitial lung
disease in six patients, chronic thromboembolic disease
in four patients and cirrhosis in two patients.12 It is possi-
ble that these associated conditions may act as a ‘second
hit’ on a pulmonary vasculature already exposed to
increased flow leading to the development of PH.
Optimal treatment of patients with PAPVD depends
on the anatomical and haemodynamic picture. Our
practice is to recommend subsequent referral of all
patients with newly diagnosed PAPVD with or without
ASD to their regional ACHD centre for an evaluation
regarding surgical suitability. The role of PAH therapy
in patients with PAH associated with PAPVD with or
without ASD is not clear. Although there are several
case studies and small case series reporting improve-
ment with PAH therapy in patients with PAPVD and
PAH, no such patients have been studied in random-
ized controlled trials.2,15–17 Consideration for PAH ther-
apy should therefore be done on a case-by-case basis
taking into account pulmonary haemodynamics and
the extent of L-R shunt. In certain circumstances,
reassessment of haemodynamics following PAH ther-
apy may alter initial decisions regarding suitability for
intervention.
This was a retrospective study and hence data for
certain investigations, including inferior venocaval sat-
urations enabling invasive Qp:Qs calculation, were not
available for all patients. Some haemodynamic data
Figure 3 Contrast-enhanced CT scans. (A) Anomalous drainage of right superior vein into SVC (arrow). (B) SV-ASD (arrow).
(C) Anomalous drainage of left superior vein into brachiocephalic vein (arrow). (D) Enlargement of anteriorly located right heart cham-
bers in a patient with PAPVD. CT, computed tomography; PAPVD, partial anomalous pulmonary venous drainage; SV-ASD, sinus
venosus atrial septal defect; SVC, superior vena cava.
© 2020 The Authors.
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provided should be interpreted with caution: the PA
lobe in which the PAWP was measured was not
recorded, and the PAWP will be inaccurate if the cathe-
ter is wedged in an artery supplying an anomalous
lobe. In addition, previous studies have highlighted
that cardiac output measured by thermodilution may
be inaccurate in patients with LR intracardiac shunts,
which may affect the data described in patients with
PAPVD with associated ASD.18,19 We have therefore
presented data regarding Qp:Qs based on patients who
had undergone Qp and Qs measurement at CMR.
In conclusion, undiagnosed PAPVD with or without
ASD may be present in patients with suspected PH who
are referred to a specialist referral centre. The presence
or absence of PAPVD on cross-sectional imaging should
therefore be specifically assessed in all patients with
suspected PH. Radiological and physiological markers of
pulmonary blood flow are higher in patients with an
associated SV-ASD in keeping with increased L-R shunt.
Although many patients with PAPVD and PH may have
other potential causes of PH, a proportion of patients
diagnosed with PAH have isolated APVD in the absence
of other causative conditions.
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